FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
143801000052115 ett sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
1 (qualifier value) Is a General adjectival modifier false Inferred relationship Some
1 (qualifier value) Is a Number (qualifier value) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) har täljarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Mezlocillin (as mezlocillin sodium) 1 g powder for solution for injection vial har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Mezlocillin (as mezlocillin sodium) 1 g powder for solution for injection vial har täljarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Mezlocillin (as mezlocillin sodium) 1 g powder for solution for injection vial räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 2
Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
cefaklor, vattenfritt (som cefaklor) 250 milligram, tuggtablett har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
cefaklor, vattenfritt (som cefaklor) 250 milligram, tuggtablett räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely albiglutide 30 milligram/1 pen powder for conventional release solution for injection (clinical drug) har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely albiglutide 30 milligram/1 pen powder for conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely ceftizoxime (as ceftizoxime sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely ceftizoxime (as ceftizoxime sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
nonakog alfa 250 IE/injektionsflaska, frystorkat pulver till injicerbar lösning räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
nonakog alfa 250 IE/injektionsflaska, frystorkat pulver till injicerbar lösning har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Albiglutide 50 mg powder for solution for injection pen har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Albiglutide 50 mg powder for solution for injection pen räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 3
Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 2
Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Trastuzumab 440 mg powder for solution for injection vial har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Trastuzumab 440 mg powder for solution for injection vial räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely plicamycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely plicamycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Amoxicillin anhydrous (as amoxicillin) 400 mg and clavulanic acid (as clavulanate potassium) 57 mg chewable tablet har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Amoxicillin anhydrous (as amoxicillin) 400 mg and clavulanic acid (as clavulanate potassium) 57 mg chewable tablet har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 2
Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Varicella-zoster virus antibody 500 mg powder for solution for injection vial har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Varicella-zoster virus antibody 500 mg powder for solution for injection vial räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Alprostadil 20 microgram/mL solution for injection räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Alprostadil 20 microgram/mL solution for injection har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Cefoxitin (as cefoxitin sodium) 10 g powder for solution for injection vial har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Cefoxitin (as cefoxitin sodium) 10 g powder for solution for injection vial räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely alprostadil 10 microgram/1 milliliter conventional release solution for injection (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely alprostadil 10 microgram/1 milliliter conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely dyclonine hydrochloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely dyclonine hydrochloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Sodium chloride 9 mg/mL solution for ocular irrigation räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Sodium chloride 9 mg/mL solution for ocular irrigation har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Drotrecogin alfa 5 mg powder for solution for injection vial räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Drotrecogin alfa 5 mg powder for solution for injection vial har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely cefaclor anhydrous (as cefaclor) 37.4 milligram/1 milliliter conventional release oral suspension (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely cefaclor anhydrous (as cefaclor) 37.4 milligram/1 milliliter conventional release oral suspension (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 2
Product containing precisely levofloxacin anhydrous (as levofloxacin) 15 milligram/1 milliliter conventional release eye solution (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely levofloxacin anhydrous (as levofloxacin) 15 milligram/1 milliliter conventional release eye solution (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Polymyxin B (as polymyxin B sulfate) 500000 unit powder for solution for injection vial har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Polymyxin B (as polymyxin B sulfate) 500000 unit powder for solution for injection vial räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
peginterferon alfa-2b 150 mikrogram, pulver till injektionsvätska, lösning, förfylld penna har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
peginterferon alfa-2b 150 mikrogram, pulver till injektionsvätska, lösning, förfylld penna räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
nonakog alfa 1 000 IE/injektionsflaska, frystorkat pulver till injicerbar lösning räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
nonakog alfa 1 000 IE/injektionsflaska, frystorkat pulver till injicerbar lösning har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely cefalexin anhydrous (as cefalexin) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely cefalexin anhydrous (as cefalexin) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 3
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
nonakog alfa 500 IE/injektionsflaska, frystorkat pulver till injicerbar lösning har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
nonakog alfa 500 IE/injektionsflaska, frystorkat pulver till injicerbar lösning räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely streptokinase 1.5 million unit/1 vial powder for conventional release solution for injection (clinical drug) har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely streptokinase 1.5 million unit/1 vial powder for conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely cefamandole (as cefamandole nafate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) har täljarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely cefamandole (as cefamandole nafate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely cefamandole (as cefamandole nafate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Interferon beta-1a 30 microgram/mL solution for injection har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Interferon beta-1a 30 microgram/mL solution for injection räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 3
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1

Start Previous Page 200 of 215 Next End


This concept is not in any reference sets

Back to Start